NZ505614A - Pentasaccharides and pharmaceutical compositions thereof, useful as anti blood clotting agnets - Google Patents

Pentasaccharides and pharmaceutical compositions thereof, useful as anti blood clotting agnets

Info

Publication number
NZ505614A
NZ505614A NZ505614A NZ50561499A NZ505614A NZ 505614 A NZ505614 A NZ 505614A NZ 505614 A NZ505614 A NZ 505614A NZ 50561499 A NZ50561499 A NZ 50561499A NZ 505614 A NZ505614 A NZ 505614A
Authority
NZ
New Zealand
Prior art keywords
pentasaccharides
useful
agnets
pharmaceutical compositions
blood clotting
Prior art date
Application number
NZ505614A
Other languages
English (en)
Inventor
Maurice Petitou
Original Assignee
Sanofi Synthelabo
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo, Akzo Nobel Nv filed Critical Sanofi Synthelabo
Publication of NZ505614A publication Critical patent/NZ505614A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NZ505614A 1998-01-19 1999-01-13 Pentasaccharides and pharmaceutical compositions thereof, useful as anti blood clotting agnets NZ505614A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9800514A FR2773801B1 (fr) 1998-01-19 1998-01-19 Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
PCT/FR1999/000045 WO1999036428A1 (fr) 1998-01-19 1999-01-13 Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
NZ505614A true NZ505614A (en) 2003-02-28

Family

ID=9521913

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ505614A NZ505614A (en) 1998-01-19 1999-01-13 Pentasaccharides and pharmaceutical compositions thereof, useful as anti blood clotting agnets

Country Status (38)

Country Link
US (1) US6670338B1 (enExample)
EP (1) EP1049706B1 (enExample)
JP (1) JP4695756B2 (enExample)
KR (1) KR100533565B1 (enExample)
CN (1) CN1172948C (enExample)
AR (1) AR012779A1 (enExample)
AT (1) ATE241637T1 (enExample)
AU (1) AU744137B2 (enExample)
BR (1) BR9907100B1 (enExample)
CA (1) CA2318326C (enExample)
CO (1) CO4970823A1 (enExample)
CZ (1) CZ299817B6 (enExample)
DE (1) DE69908298T2 (enExample)
DK (1) DK1049706T3 (enExample)
DZ (1) DZ2706A1 (enExample)
EE (1) EE04194B1 (enExample)
EG (1) EG23760A (enExample)
ES (1) ES2200494T3 (enExample)
FR (1) FR2773801B1 (enExample)
GT (1) GT199900006A (enExample)
HR (1) HRP20000479A8 (enExample)
HU (1) HU228335B1 (enExample)
IL (2) IL137240A0 (enExample)
MY (1) MY125636A (enExample)
NO (1) NO316894B1 (enExample)
NZ (1) NZ505614A (enExample)
PL (1) PL191098B1 (enExample)
PT (1) PT1049706E (enExample)
RU (1) RU2193040C2 (enExample)
SA (1) SA99191114B1 (enExample)
SI (1) SI1049706T1 (enExample)
SK (1) SK284176B6 (enExample)
TR (1) TR200002077T2 (enExample)
TW (1) TW550267B (enExample)
UA (1) UA61124C2 (enExample)
UY (1) UY25357A1 (enExample)
WO (1) WO1999036428A1 (enExample)
ZA (1) ZA99357B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
CN100513398C (zh) 2002-12-03 2009-07-15 Axys药物公司 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
KR101156273B1 (ko) * 2004-03-04 2012-06-13 프로젠 파마슈티칼즈 리미티드 황산화 올리고사카라이드 유도체
CN100338084C (zh) * 2004-07-02 2007-09-19 北京大学 抑制异种器官移植免疫排斥反应的五糖抗原的合成方法
FR2874924B1 (fr) 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) * 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
US20070191306A1 (en) * 2005-08-17 2007-08-16 Bristol-Myers Squibb Company FACTOR Xa INHIBITOR FORMULATION AND METHOD
EP1908768A1 (en) * 2006-10-05 2008-04-09 Endotis Pharma Anticoagulant compounds
CN102046781A (zh) 2008-05-30 2011-05-04 动量制药公司 糖结构以及制造和使用此类结构的方法
WO2010029552A1 (en) * 2008-09-10 2010-03-18 Transpharma Medical Ltd. Transdermal delivery of oligosaccharides
WO2011014793A2 (en) * 2009-07-31 2011-02-03 Reliable Biopharmaceutical Corporation Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
CN103917552B (zh) * 2011-06-17 2017-03-29 卡博梅麦特斯公司 具有短半衰期和高活性的合成五糖

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
DK0454220T3 (da) * 1990-04-23 1993-11-22 Sanofi Elf Carbohydratderivater omfattende en trisaccharidenhed
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ES2147216T3 (es) * 1993-09-01 2000-09-01 Akzo Nobel Nv Bisconjugados que comprenden dos sacaridos y un grupo de union.
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
CA2318326A1 (en) 1999-07-22
IL137240A0 (en) 2001-07-24
UA61124C2 (en) 2003-11-17
SI1049706T1 (en) 2003-12-31
ES2200494T3 (es) 2004-03-01
RU2193040C2 (ru) 2002-11-20
EE200000421A1 (et) 2003-06-16
CN1172948C (zh) 2004-10-27
PL191098B1 (pl) 2006-03-31
HUP0102042A1 (hu) 2001-10-28
EP1049706B1 (fr) 2003-05-28
GT199900006A (es) 2000-07-12
HUP0102042A3 (en) 2003-07-28
HU228335B1 (en) 2013-03-28
AU1974699A (en) 1999-08-02
DZ2706A1 (fr) 2003-09-01
DE69908298T2 (de) 2004-04-01
FR2773801B1 (fr) 2000-05-12
PL341874A1 (en) 2001-05-07
IL137240A (en) 2007-10-31
NO316894B1 (no) 2004-06-14
JP4695756B2 (ja) 2011-06-08
EE04194B1 (et) 2003-12-15
ZA99357B (en) 2000-07-19
MY125636A (en) 2006-08-30
US6670338B1 (en) 2003-12-30
DE69908298D1 (de) 2003-07-03
HRP20000479A2 (en) 2001-02-28
PT1049706E (pt) 2003-09-30
KR100533565B1 (ko) 2005-12-06
AU744137B2 (en) 2002-02-14
ATE241637T1 (de) 2003-06-15
HRP20000479B8 (hr) 2025-09-12
TW550267B (en) 2003-09-01
CO4970823A1 (es) 2000-11-07
AR012779A1 (es) 2000-11-08
CA2318326C (en) 2010-07-06
SK284176B6 (sk) 2004-10-05
EP1049706A1 (fr) 2000-11-08
FR2773801A1 (fr) 1999-07-23
CN1293679A (zh) 2001-05-02
CZ20002636A3 (cs) 2000-11-15
NO20003661L (no) 2000-09-19
UY25357A1 (es) 2000-12-29
BR9907100B1 (pt) 2013-09-03
SA99191114B1 (ar) 2006-10-11
JP2002509154A (ja) 2002-03-26
KR20010034205A (ko) 2001-04-25
HRP20000479A8 (hr) 2025-09-12
NO20003661D0 (no) 2000-07-17
WO1999036428A1 (fr) 1999-07-22
DK1049706T3 (da) 2003-09-29
HK1029999A1 (zh) 2001-04-20
TR200002077T2 (tr) 2000-12-21
SK10792000A3 (sk) 2001-01-18
CZ299817B6 (cs) 2008-12-03
EE200000421A (et) 2001-12-17
BR9907100A (pt) 2000-10-24
HRP20000479B1 (hr) 2006-04-30
EG23760A (en) 2007-08-08

Similar Documents

Publication Publication Date Title
AU565168B2 (en) 4:-demethyl - 4 - epipodophyllotoxin derivatives
IL138068A (en) Cyclic amino compounds and pharmaceutical compositions containing the same
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
TW334418B (en) Stilbene derivatives and pharmaceutical compositions
NO2011026I2 (no) Eribulin eller et farmasøytisk akseptabelt salt derav
DK0659174T3 (da) Derivater af valproinsyre og 2-valproensyreamider samt deres anvendelse som antikonvulsive midler
BR0110955A (pt) Derivados de tropano úteis para a terapia
LU90366I2 (fr) Nasonex
NZ279397A (en) Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives and pharmaceutucal compositions
DE69413237D1 (en) Plättchenaggregationsinhibitoren
AU4218093A (en) New peptides derived from trifluoromethyl ketones, process for their preparation and the pharmaceutical compositions which contain them
DK0421561T3 (da) 24-homo-vitamin-D-derivater, fremgangsmåder til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse som lægemiddel
BG104445A (en) NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
MY123083A (en) Acyclic nucleoside derivatives
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
UA61124C2 (en) New pentasaccharides, a method for preparing thereof and pharmaceutical compositions containing them
UA37311C2 (uk) Засіб для лікування статевої дисфункції і фармацевтичний препарат
BR9915692A (pt) Monohidrato de bromidrato de eletriptano
AU641686B2 (en) Benzanilides
NO942983L (no) Farmasöytiske sammensetninger
TW369531B (en) New taxoids, their preparation and pharmaceutical compositions containing them
IL112630A0 (en) Indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors or enkephalinase
ES466192A1 (es) Procedimiento para la obtencion de derivados de la isoqui- noleina.
IL66473A0 (en) Aminoglycoside derivatives,their production and pharmaceutical compositions containing them
HUT68015A (en) New compound leustroducsin h, its preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
ASS Change of ownership

Owner name: SANOFI-SYNTHELABO, FR

Free format text: OLD OWNER(S): SANOFI-SYNTHELABO; AKZO NOBEL N.V.

RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired